In our previous studies, we reported a series of BCL6 inhibitors with pyrimidinamine scaffold with good inhibitory activities against diffuse large B-cell lymphoma both in vitro and in vivo, but their BCL6 inhibitory activities remained at the micromolar level.26 Here, BCL6 is linked to diffuse large B-cell lymphoma.